Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on TEVA PHARMACEUTICAL INDUST
12/05 TEVA PHARMACEUTICAL INDUSTRIES : Appoints Dipankar Bhattacharjee as President an..
12/05 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Bronstein, Gewirtz & Grossman, LLC Remind..
12/05 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : ex-dividend day for final dividend
12/01 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : SHAREHOLDER ALERT - Bronstein, Gewirtz & ..
12/01 TEVA PHARMACEUTICAL INDUSTRIES : shareholder wants corruption disclosure
12/01 TEVA PHARMACEUTICAL INDUSTRIES : shareholder wants corruption disclosure
12/01 GLAXOSMITHKLINE : GSK biotech asthma drug wins UK approval after extra price cut
11/30 TEVA PHARMACEUTICAL INDUSTRIES : shareholder wants corruption disclosure
11/30DJValeant's Discussions to Sell Salix to Takeda Have Broken Down
11/30 TEVA PHARMACEUTICAL INDUSTRIES : to Present Oncology Data at the 2016 American S..
11/30 TEVA PHARMACEUTICAL INDUSTRIES : to market, distribute medical cannabis inhaler ..
11/29 Teva drugs help Mayne to strong start
11/29 Teva drugs help boost Mayne revenue
11/28 TEVA PHARMACEUTICAL INDUSTRIES : to market world's first cannabis inhaler
11/26 TEVA PHARMACEUTICAL INDUSTRIES : Aurobindo's french unit to buy products from te..
11/23 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : SHAREHOLDER ALERT - Bronstein, Gewirtz & ..
11/23 TEVA PHARMACEUTICAL INDUSTRIES : Investors With Losses In Excess of $1,000,000 A..
11/22 ROBBINS ARROYO LLP : Teva Pharmaceutical Industries Ltd. TEVA Misled Shareholder..
11/21 PINNACLE BK OF ORE : Foundry Partners LLC Decreases Stake in Teva Pharmaceutical..
11/21 TEVA PHARMACEUTICAL INDUSTRIES : Secures European Approval of Trisenox® for Firs..
11/20 CITI : Teva's generics business strong
11/19 Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 Fr..
11/17 TEVA PHARMACEUTICAL INDUSTRIES : Announces Appointment of New Chief Legal Office..
11/17 TEVA PHARMACEUTICAL INDUSTRIES : Announces Approval of Generic Tribenzor® in the..
11/17 TEVA PHARMACEUTICAL INDUSTRIES : Highlights Growing Respiratory Portfolio at the..
11/16 TEVA PHARMACEUTICAL INDUSTRIES : The Law Offices of Howard G. Smith Announces th..
11/16 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Bronstein, Gewirtz & Grossman, LLC Notifi..
11/16 TEVA PHARMACEUTICAL INDUSTRIES LTD ( : TEVA) May Settle Bribery Allegations For ..
11/15 ROBBINS ARROYO LLP : Teva Pharmaceutical Industries Ltd. (TEVA) Misled Sharehold..
11/15 Teva trims 2016 outlook on drug launch delays
11/15DJTEVA PHARMACEUTICAL INDUSTRIES : Revenue Rises on Allergan Deal -- Update
11/15 TEVA PHARMACEUTICAL INDUSTRIES : misses Street 3Q forecasts
11/15 TEVA PHARMACEUTICAL INDUSTRIES : Reports Third Quarter 2016 Results
11/15 Israeli billionaire Nacht bets big money on another Teva in healthcare
11/12 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Lundin Law PC Announces Securities Class ..
11/12 TEVA PHARMACEUTICAL INDUSTRIES : Rosen Law Firm Announces Filing of Securities C..
11/11 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Khang & Khang LLP Announces Securities Cl..
11/10 TEVA PHARMACEUTICAL INDUSTRIES : to Report Third Quarter 2016 Financial Results ..
11/10 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Lundin Law PC Announces Securities Class ..
11/10TEVA PHARMACEUTICAL INDUSTRIES LIMIT : quaterly earnings release
11/09 Pharma, biotech shares soar as Trump win calms pricing talk
11/09 Pharma, biotech shares soar as Trump win calms pricing talk
11/09 Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Phar..
11/09 TEVA PHARMACEUTICAL INDUSTRIES : Announces Appointment of New Chief Legal Office..
11/09 Law Offices of Howard G. Smith Commences Investigation on Behalf of Teva Phar..
11/09 ANTARES PHARMA, INC. (NASDAQ : ATRS) Files An 8-K Reports Third Quarter 2016 Fin..
11/08 Lundin Law PC Announces Securities Class Action Lawsuit against Teva Pharmace..
11/08 TEVA PHARMACEUTICAL INDUSTRIES : Announces Appointment of New Chief Legal Office..
11/08 Goldberg Law PC Announces Securities Class Action Lawsuit against Teva Pharma..
11/07 Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Phar..
11/07 TEVA PHARMACEUTICAL INDUSTRIES : FDA approves Teva generic blood pressure drug
11/07 ALLERGAN : Analysts put Teva's exposure at $700m
11/07 Erythropoietin Market (EPO) with Focus on Asia – Industry Analysis with..
11/07 Lundin Law PC Announces Securities Class Action Lawsuit against Teva Pharmace..
11/07 TEVA PHARMACEUTICAL INDUSTRIES : Announces Approval of Generic Tribenzor® in the..
11/07 TEVA PHARMACEUTICAL INDUSTRIES : Highlights Growing Respiratory Portfolio at the..
11/07 Goldberg Law PC Announces Securities Class Action Lawsuit against Teva Pharma..
11/06 ALLERGAN : Teva slide gains momentum amid price-fixing reports
11/04 Lundin Law PC Announces an Investigation of Teva Pharmaceutical Industries Li..
11/04 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Bronstein, Gewirtz & Grossman, LLC Announ..
11/04 Khang & Khang LLP Announces an Investigation of Teva Pharmaceutical Industrie..
11/04 Lundin Law PC Announces an Investigation of Teva Pharmaceutical Industries Li..
11/04 SHAREHOLDER ALERT :  Investigation of Teva Pharmaceutical Announced by Holzer & ..
11/04 Drugmakers under fire for possible U.S. price fixing
11/04 Goldberg Law PC Announces an Investigation of Teva Pharmaceutical Industries ..
11/04 GLANCY PRONGAY & MURRAY LLP : Commences Investigation on Behalf of Teva Pharmace..
11/02 Allergan CEO takes blame for big miss on quarterly earnings
11/02 TEVA PHARMACEUTICAL INDUSTRIES : CMS Establishes Unique J-Code for BENDEKA® (Ben..
11/01DJValeant, Saddled With Debt, in Talks to Sell Big Drug Line
11/01 MERRIMACK PHARMACEUTICALS INC (NASDA : MACK) Sees Earnings Boost As FDA Accepts ..
11/01 TEVA PHARMACEUTICAL INDUSTRIES LTD ( : TEVA) Requests Stricter Approval Requirem..
10/31 NOVARTIS : Teva tries to delay generic double dose Copaxone
10/31 MSCI : move on Teva a blow to TASE
10/31 TEVA PHARMACEUTICAL INDUSTRIES : to Report Third Quarter 2016 Financial Results ..
10/30 NOVARTIS : Teva attempts to delay generic double dose Copaxone
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ($)
Sales 2016 22 444 M
EBIT 2016 7 361 M
Net income 2016 3 321 M
Debt 2016 25 826 M
Yield 2016 3,09%
P/E ratio 2016 8,62
P/E ratio 2017 7,12
EV / Sales 2016 2,85x
EV / Sales 2017 2,26x
Capitalization 38 150 M
More Financials
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Full-screen chart
Technical analysis trends TEVA PHARMACEUTIC...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 63,8 $
Spread / Average Target 69%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Erez Vigodman President, Chief Executive Officer & Director
Yitzhak Peterburg Chairman
Carlo de Notaristefani President & CEO-Global Operations
Eyal Desheh Chief Financial Officer & Group Executive VP
Michael R. Hayden President-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL IN..-43.10%38 150
JOHNSON & JOHNSON9.00%304 591
PFIZER INC.-2.01%191 942
ROCHE HOLDING LTD.-20.19%188 878
NOVARTIS AG-19.07%178 737
MERCK & CO., INC.15.73%168 544
More Results